Enron Mail

From:brown_mary_jo@lilly.com
To:
Subject:ISIS 3521 Release
Cc:
Bcc:
Date:Mon, 5 Nov 2001 12:56:27 -0800 (PST)


We thought you might be interested in this ISIS press release regarding the compound we are developing with ISIS for the treatment of non-small cell lung cancer.


- ISIS 3521 - AACR.NCI.EORTC Meeting - 10.29.doc